Fraser obtained an MSci(Hons) in Chemistry from the University of Strathclyde in 2009, which was followed by a PhD under the supervision of Prof. Colin J. Suckling OBE, at the same institution awarded in 2012. His doctoral studies spanned computational and synthetic medicinal chemistry, and microbiology, focussed on developing Minor Groove Binders as novel anti-infective agents. During this time, Fraser also obtained a BA(Hons) in Mathematics and Statistics, and a BSc(Hons) in Computing with Mathematical Sciences, with the Open University.

​Following the completion of his doctorate in 2012, Fraser obtained a PGDE in Chemistry and an MEd in Education studies whilst embarking on a short career in Secondary School education in Scotland. In 2014 he returned to the research group of Prof. Colin J. Suckling OBE at the University of Strathclyde to take up a Post-Doctoral position that included project managing the, now commercial, Minor Grove Binder drug discovery project, alongside medicinal chemistry, chemical biology and microbiology investigations. During this time, Fraser also completed an MSc in Teaching and Learning in Higher Education and was employed as an associate lecturer in Mathematics by the Open University.

​In 2016, Fraser took up a position as a Senior Lecturer in Organic Chemistry at the University of Lincoln, before moving to the University of Huddersfield as Senior Lecturer in Pharmacology later that year. In 2019, Fraser took up his current position as a Chancellor's Fellow at the University of Strathclyde

Fraser's research interests lie within the filed of anti-infective drug discovery. He is principally focused on developing the novel class of anti-infective agent Strathclyde Minor Groove Binders (S-MGBs) to contribute to global biosecurity threat preparedness.